Some people think microdosing psychedelics can boost mood, creativity, and more. No arrows from existing clinical evidence point to starting a GLP-1 drug with the intention of microdosing it. The results of Dr. Biermann’s study aren’t published yet, but his initial data shows that spacing out how often patients took their medication could be an effective maintenance strategy for people who never reach the maximum dose.

Is It Safe to Microdose GLP-1s? Here’s What Doctors Want You to Know

However, they are Schedule I substances under the Controlled Substances Act, making them illegal to consume in any quantity. Psilocybin and LSD, for example, are commonly cited in microdosing research. There is a risk of taking too much and experiencing an unwanted psychedelic “trip.”

There is no definitive evidence yet that microdosing with psychedelics is either effective or safe.

• Studies such as this one support the hypothesis that the effect people receive from psychedelics at these subperceptual doses is mostly an expectancy effect, and that one needs to consume a higher dosage to receive a therapeutic benefit.
• While these substances tend to have low physiological risks, full doses do place people at the risk of experiencing psychological side effects including what is popularly referred as having a “bad trip.”
• Instead, they come from anecdotal evidence, the observations of people who have microdosed.
• A 2023 review suggests that microdoses of psilocybin could help to enhance creativity in adults.
• There is a risk of taking too much and experiencing an unwanted psychedelic “trip.”

That said, there may be factors like side effects that prompt doctors to consider deviating from the FDA’s dosing guidance. And then I even had a handful of patients that were taking less frequently than that, and people maintaining their weight doing that.” “Several patients in my study were taking them every 10 days instead of every week,” he says.

What does “microdosing” GLP-1 drugs really mean?

Some studies indicate a very real and significant benefit types of drug addictions from microdosing, whereas others are much less convincing and show little to no benefit. At least one state (Oregon), and many cities around the country, have decriminalized psychedelics at the local level. We don’t know as much about safety as we might have learned if not for the War on Drugs, which curtailed much of the research into psychedelics starting in the late 1960s. The drug could be adulterated (mixed in) with substances of a lower quality or dangerous product. It also means people consuming these substances cannot access a controlled, safe supply.

About Medical News Today

• Some people may be very sensitive to the compounds in common hallucinogens.
• Some drugs don’t mix well with them.
• This article explains the current research on how microdosing works, its benefits, potential risks and side effects, and whether it is legal.

In 2017, Okour et al published the first example in literature of a termination of an oral drug based on IV microdose data. “If the story about ‘Clearlight Brand “microdose” LSD’ is true, then the origin of the term ‘microdose’ for very small doses of LSD precedes all other uses of the term, e.g. in pharmacology (since 1995), in agriculture (since 2005) and by Fadiman (2011).” For safety reasons, these patients are typically excluded from studies involving psychedelic drugs. It is important to mention that the use of all psychedelic drugs should be undertaken with utmost caution — if they should be used at all — in patients with major mental illness such as schizophrenia or bipolar disorder.

Creativity

Skeptics are worried that uncontrolled access to these drugs might affect patients with mental illness, or might even precipitate mental illness such as psychosis in people that are vulnerable. It is anticipated by experts in the field that some psychedelics may become fully legalized — for medical usage, under supervision — within the next few years, specifically psilocybin and MDMA (ecstasy). Further, psychedelics such as psilocybin and LSD can produce physiological tolerance, which might suggest that, even if microdosing does help, there could be diminishing returns if one stays at the same dosage.

Psychedelic

Early research on the use of psychedelics showed a number of beneficial effects. The legality of the practice depends on the substances used—two of the most popular substances are illegal, but some others can be legally microdosed. The amount of the substance that is used is significantly below a hallucinogenic dose, yet proponents believe that the practice can produce a range of positive health effects.

Like the benefits, the potential risks of microdosing are not fully understood due to a lack of clinical research trials on humans. The potential benefits of microdosing may include improvements in mood, sleep, and eating habits, among others. Proponents say that the practice improves mental health, reduces anxiety, and may even help keep the person focused or creative throughout the day.

Popular in Grammar & Usage

Microdosing means taking a tiny fraction of a full dose of psychedelic substances, such as lysergic acid diethylamide (LSD or “acid”) or psilocybin mushrooms (magic mushrooms). Microdosing is not for everyone, and people with mental health disorders or symptoms should not use the practice to replace any treatment. However, there is not much formal research into this practice yet, partly because most substances that people microdose are illegal and difficult to research. Drug tests that check for these substances may be able to pick up on microdoses. A 2019 study notes that roughly a fifth of those that microdose report some kind of psychological or physical negative effects. A 2023 review suggests that microdoses of psilocybin could help to enhance creativity in adults.

Also, MDMA has shown some benefits in the treatment of post-traumatic stress disorder (PTSD). These include such things as improved mental clarity, greater empathy, and higher levels of extraversion. Cognitive and social benefits are also commonly reported. People who report microdosing often do so in order to help alleviate the symptoms of stress, anxiety, or depression.

Greater openness, curiosity, shifting perspectives, and overall greater feelings of creativity are commonly reported benefits. Such studies may not give a full depiction of the practice, since most of these participants already expect to have a good experience so their feedback may be biased. These tend to be the most researched and are often easier to obtain than some lesser-used substances.

Researchers are investigating into microdosing more and more, the placebo effect causes difficulties in research on this topic. More research is needed to ultimately decide whether or not microdosing helps those who suffer from depression and anxiety.